Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × Interleukin-2 × Clear all

Phase

Phase 1/2 3 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 39 Carcinoma, Renal Cell 17 Neoplasm Metastasis 16 Kidney Neoplasms 12 Leukemia, Myeloid, Acute 11 Skin Neoplasms 10 Neoplasms 10 Leukemia 7 Breast Neoplasms 7 Lymphoma, Non-Hodgkin 5 Ovarian Neoplasms 4 Neuroblastoma 4 Myelodysplastic Syndromes 4 Congenital Abnormalities 4 Lymphoma 3 Colorectal Neoplasms 3 Uveal Melanoma 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Hodgkin Disease 2 Fallopian Tube Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Recurrence 1

Interventions

Cisplatin 80 Fluorouracil 66 Paclitaxel 62 Radiotherapy 56 Oxaliplatin 51 Irinotecan 35 Docetaxel 34 Leucovorin 32 Carboplatin 30 Capecitabine 26 Radiation 25 Surgical Procedures, Operative 20 pembrolizumab 17 Drug Therapy 15 Bevacizumab 15 Cetuximab 14 Nivolumab 12 tislelizumab 11 Chemoradiotherapy 11 Albumin-Bound Paclitaxel 10 camrelizumab 9 S 1 (combination) 9 Neoadjuvant Therapy 9 Esophagectomy 9 nimotuzumab 8 durvalumab 8 Trastuzumab 8 Radiotherapy, Intensity-Modulated 7 Gefitinib 7 nedaplatin 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01795976 2018-08-07

ATTACK-OG

The Christie NHS Foundation Trust

Phase 2 Terminated

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡